Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:AbbVie
$5.8 billion |
| gptkbp:acquisitionYear |
2016
|
| gptkbp:focusesOn |
cancer therapeutics
|
| gptkbp:foundedBy |
gptkb:Brian_Slingerland
|
| gptkbp:foundedYear |
2008
|
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Stemcentrx
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableInvestment |
gptkb:Founders_Fund
gptkb:Sequoia_Capital gptkb:Artis_Ventures |
| gptkbp:notableProduct |
gptkb:Rova-T
|
| gptkbp:numberOfEmployees |
~200 (at time of acquisition)
|
| gptkbp:website |
https://www.stemcentrx.com/
|
| gptkbp:bfsParent |
gptkb:Brian_Singerman
|
| gptkbp:bfsLayer |
6
|